ConductScience.org, home

Paper41324239

Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial.

Vajgel G and 7 others. Nephrol Dial Transplant, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial. Papers, record 41324239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41324239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial.
PubMed
Journal
Nephrol Dial Transplant
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-07-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vajgel GGiselehttps://orcid.org/0000-0002-2606-3638
2Júnior BMDSBraziliano Miguel da Silva
3Filho CRSMCarlos R Silva Miranda
4de Oliveira CBLCamila Barbosa Lyrahttps://orcid.org/0000-0003-2080-923X
5Costa DMDNDenise Maria do Nascimento
6de Lima CADCamilla Albertina Dantas
7Valente LMLucila Maria
8Sandrin-Garcia PPaula

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucosidesMajor topic
Lupus NephritisMajor topic
Benzhydryl CompoundsMajor topic
ProteinuriaMajor topic
Humans
Female
Adult
Male
Glomerular Filtration Rate
Cross-Over Studies
Follow-Up Studies
Middle Aged
Prognosis
Kidney Function Tests

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CNPqPubMed
CAPESPubMed
FACEPEPubMed

Source PubMed

Download CSV of grants

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42951286
Effect of dapagliflozin on renal response in patients with biopsy-confirmed lupus nephritis receiving stable maintenance immunosuppression and renin-angiotensin system inhibition: protocol for the multicentre randomised DAPA-LN trial.
Lupus Sci Med2026https://conductscience.org/library/papers/42951286PubMed
42940159Real-World Renal Effects of Dapagliflozin in Bulgarian Patients with Chronic Kidney Disease of Predominantly Glomerular Origin: A Two-Year Comparative Cohort Study with Historical Controls.Biomedicines2026https://conductscience.org/library/papers/42940159PubMed
42182829Sodium-Glucose Cotransporter 2 Inhibitors in Lupus Nephritis and ANCA-Associated Vasculitis: Unmet Needs to be Addressed.Glomerular Dis2026https://conductscience.org/library/papers/42182829PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41324239

GET https://conductscience.org/api/papers/v1/41324239/authors